A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: There remains an unmet need
- 30 April 2006
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 151 (4) , 771-778
- https://doi.org/10.1016/j.ahj.2005.06.014
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Ximelagatran versus warfarin forstroke prevention in patientswith nonvalvular atrial fibrillation: SPORTIF ii: a dose-guiding, tolerability, and safety studyJournal of the American College of Cardiology, 2003
- A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial FibrillationNew England Journal of Medicine, 2002
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- Atrial Fibrillation in Heart FailureNew England Journal of Medicine, 1999
- Treatment of atrial fibrillation in a district general hospital.Heart, 1994
- Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring studyAmerican Heart Journal, 1992
- Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillationThe American Journal of Cardiology, 1987
- Coronary heart disease and atrial fibrillation: The Framingham StudyAmerican Heart Journal, 1983